ALKEM LABORATORIES
Quarterly Results Analysis [Dec2024]
ALKEM LABORATORIES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹3,374 Cr | ₹3,415 Cr | ₹3,032 Cr | ₹2,936 Cr | ₹3,324 Cr | ₹3,440 Cr | ₹2,968 Cr | ₹2,903 Cr |
Expenses | ₹2,615 Cr | ₹2,662 Cr | ₹2,423 Cr | ₹2,534 Cr | ₹2,616 Cr | ₹2,693 Cr | ₹2,579 Cr | ₹2,549 Cr |
Operating Income | ₹759 Cr | ₹753 Cr | ₹609 Cr | ₹402 Cr | ₹708 Cr | ₹747 Cr | ₹389 Cr | ₹353 Cr |
Other Income | ₹93 Cr | ₹134 Cr | ₹120 Cr | ₹88 Cr | ₹94 Cr | ₹63 Cr | ₹66 Cr | ₹69 Cr |
Interest | ₹36 Cr | ₹28 Cr | ₹29 Cr | ₹27 Cr | ₹25 Cr | ₹30 Cr | ₹30 Cr | ₹29 Cr |
Depreciation | ₹85 Cr | ₹79 Cr | ₹80 Cr | ₹83 Cr | ₹70 Cr | ₹74 Cr | ₹72 Cr | ₹78 Cr |
Profit Before Tax | ₹731 Cr | ₹780 Cr | ₹619 Cr | ₹367 Cr | ₹655 Cr | ₹648 Cr | ₹353 Cr | ₹212 Cr |
Profit After Tax | ₹641 Cr | ₹702 Cr | ₹550 Cr | ₹304 Cr | ₹604 Cr | ₹615 Cr | ₹288 Cr | ₹68 Cr |
EPS | ₹52.35 | ₹57.60 | ₹45.60 | ₹24.56 | ₹49.77 | ₹51.90 | ₹23.98 | ₹5.94 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALKEM LABORATORIES | 0.6% | -8.4% | -8.5% |
SUN PHARMACEUTICAL INDUSTRIES | -3% | -8.7% | 4.1% |
DIVIS LABORATORIES | -4.7% | -4.5% | 58.5% |
CIPLA | -4.3% | -3.2% | -3.2% |
TORRENT PHARMACEUTICALS | -3% | -12.3% | 13.8% |
DR REDDYS LABORATORIES | -3% | -6.5% | -12.7% |
MANKIND PHARMA | -1.6% | -8% | 9.4% |
ZYDUS LIFESCIENCES | -1% | -8.1% | -5.9% |
LUPIN | NA | -7.7% | 16.6% |
ALKEM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.18 % |
Y-o-Y | 1.52 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹3,374 Cr | -1.18 | |
Sep2024 | ₹3,415 Cr | 12.63 | |
Jun2024 | ₹3,032 Cr | 3.27 | |
Mar2024 | ₹2,936 Cr | -11.67 | |
Dec2023 | ₹3,324 Cr | -3.38 | |
Sep2023 | ₹3,440 Cr | 15.92 | |
Jun2023 | ₹2,968 Cr | 2.24 | |
Mar2023 | ₹2,903 Cr | - |
ALKEM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 0.87 % |
Y-o-Y | 7.32 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹759 Cr | 0.87 | |
Sep2024 | ₹753 Cr | 23.69 | |
Jun2024 | ₹609 Cr | 51.41 | |
Mar2024 | ₹402 Cr | -43.19 | |
Dec2023 | ₹708 Cr | -5.24 | |
Sep2023 | ₹747 Cr | 91.87 | |
Jun2023 | ₹389 Cr | 10.17 | |
Mar2023 | ₹353 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.09 % |
Y-o-Y | 5.73 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 22.51% | 2.09 | |
Sep2024 | 22.05% | 9.81 | |
Jun2024 | 20.08% | 46.68 | |
Mar2024 | 13.69% | -35.70 | |
Dec2023 | 21.29% | -1.93 | |
Sep2023 | 21.71% | 65.60 | |
Jun2023 | 13.11% | 7.72 | |
Mar2023 | 12.17% | - |
ALKEM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -8.71 % |
Y-o-Y | 6.04 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹641 Cr | -8.71 | |
Sep2024 | ₹702 Cr | 27.57 | |
Jun2024 | ₹550 Cr | 80.71 | |
Mar2024 | ₹304 Cr | -49.61 | |
Dec2023 | ₹604 Cr | -1.73 | |
Sep2023 | ₹615 Cr | 113.64 | |
Jun2023 | ₹288 Cr | 325.25 | |
Mar2023 | ₹68 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -7.64 % |
Y-o-Y | 4.46 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 18.99 % | -7.64 | |
Sep2024 | 20.56 % | 13.28 | |
Jun2024 | 18.15 % | 75.02 | |
Mar2024 | 10.37 % | -42.96 | |
Dec2023 | 18.18 % | 1.73 | |
Sep2023 | 17.87 % | 84.23 | |
Jun2023 | 9.7 % | 316.31 | |
Mar2023 | 2.33 % | - |
ALKEM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -9.11 % |
Y-o-Y | 5.18 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹52.35 | -9.11 | |
Sep2024 | ₹57.6 | 26.32 | |
Jun2024 | ₹45.6 | 85.67 | |
Mar2024 | ₹24.56 | -50.65 | |
Dec2023 | ₹49.77 | -4.10 | |
Sep2023 | ₹51.9 | 116.43 | |
Jun2023 | ₹23.98 | 303.70 | |
Mar2023 | ₹5.94 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD